1. Prospective Study of Dietary Zinc Intake and Risk of Cardiovascular Disease in Women.
- Author
-
Milton AH, Vashum KP, McEvoy M, Hussain S, McElduff P, Byles J, and Attia J
- Subjects
- Australia epidemiology, Biomarkers blood, Cardiovascular Diseases blood, Cardiovascular Diseases diagnosis, Female, Humans, Incidence, Iron blood, Linear Models, Logistic Models, Longitudinal Studies, Middle Aged, Multivariate Analysis, Nutritional Status, Odds Ratio, Preliminary Data, Prospective Studies, Risk Factors, Time Factors, Zinc administration & dosage, Zinc blood, Cardiovascular Diseases epidemiology, Diet adverse effects, Zinc adverse effects
- Abstract
Several animal and human studies have shown that zinc is associated with cellular damage and cardiac dysfunction. This study aims to investigate dietary zinc and the zinc-iron ratio, as predictors of incident cardiovascular disease (CVD) in a large longitudinal study of mid-age Australian women (aged 50-61 years). Data was self-reported and validated food frequency questionnaires were used to assess dietary intake. Energy-adjusted zinc was ranked using quintiles and predictors of incident CVD were examined using stepwise logistic regression. After six years of follow-up, 320 incident CVD cases were established. A positive association between dietary zinc intake, zinc-iron ratio and risk of CVD was observed even after adjusting for potential dietary and non-dietary confounders. Compared to those with the lowest quintile of zinc, those in the highest quintile (Odds Ratio (OR) = 1.67, 95% Confidence Interval (CI) = 1.08-2.62) and zinc-iron ratio (OR = 1.72, 95% CI = 1.05-2.81) had almost twice the odds of developing CVD ( p trend = 0.007). This study shows that high dietary zinc intake and zinc-iron ratio is associated with a greater incidence of CVD in women. Further studies are required detailing the source of zinc and iron in diet and their precise roles when compared to other essential nutrients., Competing Interests: The authors declare no conflict of interest. The founding sponsor had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, and in the decision to publish the results.
- Published
- 2018
- Full Text
- View/download PDF